BackBetter Therapeutics- Tradeable Rights - March 2021 Overview

Better Therapeutics- Tradeable Rights - March 2021 Goodwill

Track Better Therapeutics- Tradeable Rights - March 2021's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average / median

Loading

Better Therapeutics- Tradeable Rights - March 2021 Goodwill History

Loading

Better Therapeutics- Tradeable Rights - March 2021 vs. peers: Goodwill Comparison

Loading

Better Therapeutics- Tradeable Rights - March 2021 Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Better Therapeutics- Tradeable Rights - March 2021 (MCADR) FAQ

As of the most recent data (September 2023), MCADR shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCADR's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics- Tradeable Rights - March 2021 is outperforming or lagging.

Tracking MCADR's goodwill over time shows whether Better Therapeutics- Tradeable Rights - March 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Better Therapeutics- Tradeable Rights - March 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.